IL1A and HIV infectious disease: This study found no statistically significant changes in CVF soluble markers of immune activation and inflammation between IVR insertion and removal, except for a significant decrease in SLPI, an immune mediator previously shown to block HIV infection, and an increase in the inflammatory cytokine IL-1α (33, 34) in the TFV only group.